| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88585560 | FILING DATE | 08/20/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MCCAULEY, BRENDAN D |
L.O. ASSIGNED | 114 |
PUB INFORMATION |
|||
| RUN DATE | 12/20/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 12/19/2019 | ||
| LITERAL MARK ELEMENT | BYONDIS | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | YES | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | BYONDIS |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Synthon Biopharmaceuticals B.V |
| ADDRESS | Microweg 22 CM Nijmegen, 6545 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Netherlands |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Biopharmaceutical preparations, substances and compositions, namely, antibacterial substances for medical purposes, medical diagnostic reagents in the nature of antibody-drug conjugates, immuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncology, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biopharmaceutical active substances, namely, diagnostic agents, preparations and substances for medical purposes in the nature of antibody-drug conjugates, immuno-oncology compounds, namely, pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological and biochemical drug and cultures for medical use, namely, biological preparations for the treatment of cancer, cultures of microorganisms for medical use, and biological tissue cultures for medical purposes; biopharmaceutical active substances, namely, nutritive substances for microorganism cultures; biopharmaceutical components and ingredients, namely, plant and herb extracts sold as components of medicated cosmetics; orthopedic articles, namely, bone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Surgical and medical devices, apparatus and instruments, namely, surgical instruments and apparatus, surgical devices and instruments, surgical apparatus and instruments, medical instruments for cutting tissue, and medical instrument for performing biopsies, medical fluid injectors, injection device for pharmaceuticals, syringes for medical purposes, disposable syringes for medical purposes; orthopedic articles, namely, orthopedic walkers, orthopedic supports, orthopedic braces and orthopedic cushions; injection apparatus for medical purposes, namely, injection needles and injection instruments with needles |
| INTERNATIONAL CLASS | 035 |
| DESCRIPTION TEXT | Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transactions for others, mediation of contracts for the purchase and sale of products, and mediation of agreements all in the field of the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files, namely, scientific research in the field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical research consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biology, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information regarding the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory research, namely, scientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality control, namely, material testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceutical, biopharmaceutical and medical fields |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 035 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Benelux |
| APPLICATION NO. | 1399914 |
| APPLICATION FILING DATE | 07/30/2019 |
| FOREIGN REG NO. | 1399914 |
| FOREIGN REG DATE | 08/07/2019 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 07/30/2029 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/19/2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 022 |
| 12/12/2019 | DOCK | D | ASSIGNED TO EXAMINER | 021 |
| 12/11/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 020 |
| 12/11/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 019 |
| 12/11/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 018 |
| 12/11/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 017 |
| 12/11/2019 | DOCK | D | ASSIGNED TO EXAMINER | 016 |
| 12/09/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 015 |
| 12/09/2019 | GNRT | O | NON-FINAL ACTION E-MAILED | 014 |
| 12/09/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 013 |
| 12/02/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 12/02/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 11/29/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 11/20/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 009 |
| 11/20/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 008 |
| 11/20/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 007 |
| 11/19/2019 | DOCK | D | ASSIGNED TO EXAMINER | 006 |
| 11/05/2019 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 005 |
| 10/31/2019 | ALIE | A | ASSIGNED TO LIE | 004 |
| 10/25/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 003 |
| 09/05/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 08/23/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | E. Anthony Figg |
| CORRESPONDENCE ADDRESS | E. ANTHONY FIGG ROTHWELL, FIGG, ERNST & MANBECK, PC 607 14TH STREET NW SUITE 800 WASHINGTON, DC 20005 |
| DOMESTIC REPRESENTATIVE | E. Anthony Figg |